Insulet earnings were $236.1M for the trailing 12 months ending Jun 30, 2025, with -40.4% growth year over year. The latest PODD earnings report on Jun 30, 2025 announced Q2 2025 earnings of $22.5M, down 36.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PODD reported annual earnings of $418.3M, with 102.8% growth.
PODD past earnings growth
How has PODD's earnings growth performed historically?
On PODD's earnings call on Invalid Date, Insulet (NASDAQ: PODD) reported Q2 2025 earnings per share (EPS) of $0.32, up 88.1% year over year. Total PODD earnings for the quarter were $22.50 million. In the same quarter last year, Insulet's earnings per share (EPS) was $2.69.
As of the last Insulet earnings report, Insulet is currently profitable. Insulet's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $236.10 million, a 40.27% decrease year over year.
What was PODD's earnings growth in the past year?
As of Insulet's earnings date in Invalid Date, Insulet's earnings has grown -40.35% year over year. This is 125.99 percentage points lower than the US Medical Devices industry earnings growth rate of 85.63%. PODD earnings in the past year totalled $236.10 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.